SEARCH:

News for Food and Drug Administration (FDA)

News > FDA

Listings 331 - 340 of 441:

Ranbaxy Receives FDA Approval To Market Loratadine Antihistamine Tablets
Ohm Laboratories announced that RLL has received approval from the U. S. Food and Drug Administration to manufacture and commercialize its Loratadine ...

World Health Organization Forum Endorses Salt Reduction
committee convened by the World Health Organization (WHO) has published a report endorsing population-wide strategies to reduce salt consumption as a ...

Atrium Medical Receives FDA Approval for its Novel C-QURLite Mesh
Atrium Medical Corporation announced that it has obtained US FDA 510(K) approval for a new Omega 3 surgical mesh product called C-QURLite Mesh.This ne...

Ethicon Endo-Surgery Files for FDA Approval of New Gastric Band for Treatment of Morbid Obesity
Ethicon Endo-Surgery announced that it has submitted a Premarket Approval (PMA) application with the U.S. Food and Drug Administration (FDA) for its a...

FDA Licenses First Biologic Product to Prevent Hepatitis B Reinfection in
he FDA announced the approval of HepaGam B for the prevention of hepatitis B reinfection in certain liver transplant patients. HepaGam B is the first ...

FDA Provides Web Access to Information on Post-Approval Device Studies
he U.S. Food and Drug Administration (FDA) unveiled a new Web page that will keep the public informed about the status of post-approval patient studie...

FDA Re-Emphasizes Warnings to Consumers on Risks of Pet Turtles
he FDA is urgently reminding the public that contact with baby turtles can pose a serious health risk to infants, small children, and adults with impa...

Tepha Receives FDA Clearance for First Medical Device Derived from New Class of Biopolymers
Tepha announced that the FDA has cleared its TephaFLEX(R) Absorbable Suture product for marketing in the U.S. The TephaFLEX Absorbable Suture is the f...

FDA Announces Discontinued Marketing Of GI Drug, Zelnorm, For Safety Reasons, USA
The Food and Drug Administration (FDA) has requested that Novartis Pharmaceuticals Corporation of East Hanover, New Jersey, voluntarily discontinue ma...

FDA Approves First Biologic To Treat Rare Clotting Disorder
The FDA licensed Ceprotin, the first biologic treatment for patients with a rare genetic defect that can cause a potentially life-threatening clotting...

Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 Next

Get Free Security Resources from Symantec